We’re excited to announce a new collaboration with @EliLillyandCo to build next-gen #machinelearning models for small molecule design. Through this partnership, we’ll train advanced #ML models on Lilly’s rich preclinical dataset to overcome a longstanding problem in drug

Gabriel blends biology & #ML to drive small molecule #drugdevelopment. From melanoma research to a Master’s at UCL to presenting insitro’s KinDEL dataset @ ICML, his career advances drug discovery w/ scalable data & predictive modeling. Read Gabriel's Meet the insitrocyte below.

7️⃣ years using #machinelearning and data at scale to understand disease better and bring medicines to patients who can benefit most. Cheers to our team, our partners, and the belief that better is always possible. ✨

🎙️Tune in to Episode 197 of #TheGeneticsPodcast 🚀 This week, we’re joined by Heiko Runz, medical geneticist and VP of Neuroscience at @insitro . Listen in to hear about @heikorunz's path from academia to industry, his role in developing tofersen for SOD1 ALS, how he integrates

“You can use AI for good, like making better medicines.” @DaphneKoller joins @FortuneMagazine’s #LeadershipNext to talk about #AI scenarios, preparing for careers in the AI era as well as insitro’s next chapter and the value of connecting the dots. Listen below. ⬇️

When it comes to understanding disease, the eye is the window to the entire body. To mark #Alzheimers & Brain Awareness Month, #ENDALZ this June, we share a “behind-the-scenes” look at our latest collaboration that is leveraging the world’s largest imaging bioresource containing

Our insitrocytes work with intention to create a space where innovation and authenticity go hand in hand. Employee resource groups like Outsitro help foster belonging across teams, while collaborative efforts like POSH bring those values into our scientific work and enable us to

We’re excited for #BIO2025! insitro CFO/CBO Mary Rozenman joins a panel June 16 on how #AI is reshaping #drugdiscovery. Mary and Dave Light, insitro VP, Corporate Development & Strategy, will be sharing more about how insitro integrates #ML into every step of R&D, to generate

The @KeystoneSymp’s joint conference is coming up in Whistler, BC, Canada! insitro’s Director Max Salick will be presenting at “The Digital Era in Neurodegeneration and Neuroinflammation” to share recent research and technological advances on our POSH platform from the insitro

Today insitro announces an exciting new collaboration with the INSIGHT Health Research Data Hub at Moorfields Eye Hospital, London, through the development of a novel #AI foundation model to identify and to support #drugdiscovery. Learn more: https://t.co/ask6dLL1nB

Join insitro CEO and founder @DaphneKoller at WIRED Health in London next Tuesday, March 18 as she takes the keynote stage!📣 Daphne will be sharing an inside look at how insitro’s approach to #drugdiscovery is building a pipeline of high-conviction targets through

Thank you @Forbes for including insitro as a Best Startup Employer for the fourth year running! 👏 Our insitrocytes are working every day to deliver better medicines for patients using the power of machine learning and data at scale, so we can make medicines ... differently.

insitro CFO/CBO @mmrozenman joins @BiocomCA Global Life Science Partnering & Investor Conference alongside #biotech and pharma peers for the “AI & Drug Discovery: It’s Not As Easy As It Looks” panel. Learn more at: https://t.co/UpYmTciOQu

Thanks to the @SFBusinessTimes for including insitro CEO and founder @DaphneKoller in their Newsmakers 100 list, recognizing the great partnerships and developments we announced with both @EliLillyandCo and @bmsnews in 2024. 🌟 Read more about Daphne and the other impressive

Our insitrocytes are the heartbeat of our shared vision. Together, as builders, scientists, engineers, we solve complex challenges every day, laser-focused on delivering better medicines for patients. Hear directly from some of our colleagues about how we work. Visit

Big thanks to @BrunswickGroup’s @reutersBenHir who recently spoke with insitro CFO/CBO @mmrozenman on the potential of #AI and machine learning in #drugdiscovery. This piece also shows how @uk_biobank (and insitro partner) contributes to the success in developing therapeutics

Exclusive: Insitro, an AI-powered biotech, is making strides in the challenging field of ALS drug discovery, identifying a novel target in partnership with Bristol Myers Squibb.

Excited to share the selection of a first novel target for #ALS and $25 mln payment from our collaboration w/@bmsnews for target discovery. Check out the video below.

🎉We have been named to @BioSpace’s 2025 Best Places to Work! We take pride in building a culture that’s greater than the sum of its parts. This recognition speaks to our collective efforts - we’re proud of who we are and our efforts to transform drug discovery using #ML & #AI.